Search results for abx831126

Oportuzumab, Abbexa, abx831126

Oportuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting EPCAM/CD326, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. VB4-845 is studied in the treatment of certain types of head and neck cancer. VB4-845 is made by linking a monoclonal antibody fragment to a toxic protein that may kill cancer cells. VB4-845 is a fusion protein containing humanized scFv specific for the epithelial cell adhesion molecule, Ep-CAM, a tumor cell-associated target highly expressed on carcinoma cells of epithelial origin and a truncated portion of Pseudomonas exotoxin A.